| Dr Peter L Smith, MD | |
|
29 E 29th St, Vascular Center, Bayonne, NJ 07002-4654 | |
| (201) 858-4590 | |
| (201) 243-4229 |
| Full Name | Dr Peter L Smith |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 37 Years |
| Location | 29 E 29th St, Bayonne, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861497224 | NPI | - | NPPES |
| 8010803 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hudson Regional Hospital | Secaucus, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hudson Orthopedics Pain And Spine | 3476966508 | 6 |
| Center For Vascular Medicine Nj, Llc | 9830447572 | 2 |
| Bushwick Professional Medical Services Of New York Llc | 0648516617 | 2 |
| Fordham Medical Of New York Llc | 4284972621 | 16 |
| Bushwick Medical Of New York Llc | 5092068262 | 18 |
News Archive
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.
A study out this Wednesday says that insertion of an artery-opening device called a stent into the brain to improve blood flow to prevent a second stroke may do more harm than managing high-risk patients with drugs and lifestyle changes. Blocked brain arteries caused by the build-up of fatty deposits called plaque account for more than 50,000 of the 795,000 strokes occurring in the United States each year. Stroke is the fourth-leading cause of death and a leading cause of disability in the United States.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 3 days ago
| Entity Name | Imaging Guided Solutions, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700957768 PECOS PAC ID: 5496823577 Enrollment ID: O20081002000091 |
News Archive
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.
A study out this Wednesday says that insertion of an artery-opening device called a stent into the brain to improve blood flow to prevent a second stroke may do more harm than managing high-risk patients with drugs and lifestyle changes. Blocked brain arteries caused by the build-up of fatty deposits called plaque account for more than 50,000 of the 795,000 strokes occurring in the United States each year. Stroke is the fourth-leading cause of death and a leading cause of disability in the United States.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 3 days ago
| Entity Name | Center For Vascular Medicine Nj, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144761685 PECOS PAC ID: 9830447572 Enrollment ID: O20180813000737 |
News Archive
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.
A study out this Wednesday says that insertion of an artery-opening device called a stent into the brain to improve blood flow to prevent a second stroke may do more harm than managing high-risk patients with drugs and lifestyle changes. Blocked brain arteries caused by the build-up of fatty deposits called plaque account for more than 50,000 of the 795,000 strokes occurring in the United States each year. Stroke is the fourth-leading cause of death and a leading cause of disability in the United States.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 3 days ago
| Entity Name | Usa Vascular Center Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437701729 PECOS PAC ID: 1759709371 Enrollment ID: O20200915000443 |
News Archive
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.
A study out this Wednesday says that insertion of an artery-opening device called a stent into the brain to improve blood flow to prevent a second stroke may do more harm than managing high-risk patients with drugs and lifestyle changes. Blocked brain arteries caused by the build-up of fatty deposits called plaque account for more than 50,000 of the 795,000 strokes occurring in the United States each year. Stroke is the fourth-leading cause of death and a leading cause of disability in the United States.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 3 days ago
| Entity Name | Hudson Orthopedics Pain And Spine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235753633 PECOS PAC ID: 3476966508 Enrollment ID: O20210111002276 |
News Archive
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.
A study out this Wednesday says that insertion of an artery-opening device called a stent into the brain to improve blood flow to prevent a second stroke may do more harm than managing high-risk patients with drugs and lifestyle changes. Blocked brain arteries caused by the build-up of fatty deposits called plaque account for more than 50,000 of the 795,000 strokes occurring in the United States each year. Stroke is the fourth-leading cause of death and a leading cause of disability in the United States.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter L Smith, MD Po Box 17288, Jersey City, NJ 07307-7288 Ph: (201) 858-4590 | Dr Peter L Smith, MD 29 E 29th St, Vascular Center, Bayonne, NJ 07002-4654 Ph: (201) 858-4590 |
News Archive
Today, Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.
A study out this Wednesday says that insertion of an artery-opening device called a stent into the brain to improve blood flow to prevent a second stroke may do more harm than managing high-risk patients with drugs and lifestyle changes. Blocked brain arteries caused by the build-up of fatty deposits called plaque account for more than 50,000 of the 795,000 strokes occurring in the United States each year. Stroke is the fourth-leading cause of death and a leading cause of disability in the United States.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 3 days ago
Dr. Mark Hebel, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 29th Street At Avenue E, Bayonne, NJ 07002 Phone: 201-858-5461 Fax: 201-243-4229 | |
Dr. Priti Chandiwala-mody, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 29 E 29th St, Department Of Radiology, Bayonne, NJ 07002 Phone: 201-858-7341 | |
Anne Kim, Radiology Medicare: Accepting Medicare Assignments Practice Location: 27 E 29th St, Bayonne, NJ 07002 Phone: 201-436-6100 | |
Dr. Peter H Soloway, MD Radiology Medicare: Medicare Enrolled Practice Location: 657-659 Broadway, Bayonne, NJ 07002 Phone: 201-437-3007 Fax: 201-437-1418 | |
Dr. Luciano Castillo Jr., M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 29th Street At Avenue E, Bayonne, NJ 07002 Phone: 201-858-5461 Fax: 201-243-4229 | |
Dr. Marina Perlov, MD Radiology Medicare: Medicare Enrolled Practice Location: 657 659 Broadway, Bayonne, NJ 07002 Phone: 201-437-3007 Fax: 201-437-4070 |